Cargando…
A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells
We have previously demonstrated that DT-010, a novel conjugate of danshensu (DSS) and tetramethylpyrazine (TMP), displays anti-tumor effects in breast cancer cells both in vitro and in vivo. In the present study, we investigated whether DT-010 enhances the chemotherapeutic effect of doxorubicin (Dox...
Autores principales: | Wang, Liang, Chan, Judy Y., Zhou, Xinhua, Cui, Guozhen, Yan, Zhixiang, Wang, Li, Yan, Ru, Di, Lijun, Wang, Yuqiang, Hoi, Maggie P., Shan, Luchen, Lee, Simon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979254/ https://www.ncbi.nlm.nih.gov/pubmed/27559313 http://dx.doi.org/10.3389/fphar.2016.00249 |
Ejemplares similares
-
A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer
por: Zhou, Xinhua, et al.
Publicado: (2019) -
Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019) -
Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2020) -
A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor
por: Hu, Shengquan, et al.
Publicado: (2018) -
A novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II
por: Wang, Liang, et al.
Publicado: (2016)